DUBLIN--(BUSINESS WIRE)--Aug 16, 2012--Research and Markets ( ) has announced the addition of the "Global Renal Denervation Market Report: 2012 Edition" report to their offering.

Renal artery denervation (RDN) devices and technologies are the most sought after innovations in the field of medical technology as they provide for an approach for managing and controlling the resistant hypertension, something that wasn't available in the paramedics' field before.

Developing novel medical devices using technologies which employ high frequency radiations has been a widely accepted trend these days. The companies operating in this field have been manufacturing devices which are used in the diagnosis and treatment of numerous medical conditions like cancer and hypertension. Despite being a technology which principally works using radiations for medical therapy, RDN has been proven minimally invasive and efficient when practiced heedfully.

The ongoing trends in the respective market include Medtronic's HTN-3 pivotal study, development of novel renal denervation devices, devising of baroreceptor stimulation technology, ongoing clinical trials and techniques to address the existing limitations of the current technologies.

The drivers promoting RDN market's growth incorporate factors like increasing cases of hypertension, increasing expenditure on healthcare, rising adult population worldwide, and increasing global GNI. Although it's been a new development in the field of paramedics, it has its own share of difficulties and hurdles where situations and elements such as limitations of invasive technology and treatment-resistant hypertension have been posing acute challenges.

This RDN Market report attempts to elicit the rapidly evolving market by scrutinizing the novel technologies, product offerings, top notch industry players and their respective market shares.

Key Topics Covered 1. Hypertension 1.1 Overview - BP Pattern - Essential Hypertension - Treatment Options 1.2 Global Hypertension Market 1.3 The US Hypertension Market 1.4 European Hypertension Market 2. Renal Denervation 2.1 Overview 2.2 Renal Denervation Market 3. Renal Denervation - Market Dynamics 3.1 Key Trends 3.1.1 Medtronic's HTN-3 Pivotal Study 3.1.2 Development of Novel Renal Denervation Devices 3.1.3 Devising of Baroreceptor Stimulation Technology 3.1.4 Ongoing Clinical Trials 3.1.5 Addressing the Existing Limitations of the Current Technologies 3.2 Growth Drivers 3.2.1 Increasing Cases of Hypertension 3.2.2 Increasing Expenditure on Healthcare 3.2.3 Rising Adult Population Worldwide 3.2.4 Increasing Global GNI (Gross National Income) 3.3 Challenges 3.3.1 Limitations of Invasive Technology for Treatment 3.3.2 Treatment-resistant Hypertension 4. Renal Denervation - Competitive Landscape - Competitive Overview - Renal Denervation Programs - Technology Comparison 5. Company Profiles 6. RDN Market Outlook Companies Mentioned - Boston Scientific - Covidien - Medtronic - St. Jude Medical For more information, including full table of contents, please visit

CONTACT: Research and Markets Laura Wood, Senior Manager. U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector:Medical Devices KEYWORD: INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING SOURCE: Research and Markets Copyright Business Wire 2012 PUB: 08/16/2012 05:58 AM/DISC: 08/16/2012 05:58 AM